CTLA4 and breast cancer: In support of this, Chen et al. demonstrated in BC cell lines that the intrinsic expression of CTLA-4 could inhibit the processes of antigenic presentation and expression of inflammatory cytokines, preventing the proper activation of type 1 T helper (Th1) and cytotoxic T lymphocytes [61].